Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX for Premature Ejaculation
NCT01917006Phase 2Terminated
- Sponsor
- Allergan
- Start
- Aug 2013
- Primary completion
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of onabotulinumtoxinA in premature ejaculation (PE), sponsored by Allergan. Started Aug 2013; status: terminated.
02
Drugs
onabotulinumtoxinA
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT01917006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01917006.